| Year |
Citation |
Score |
| 2012 |
Bleckert A, Photowala H, Alford S. Dual pools of actin at presynaptic terminals. Journal of Neurophysiology. 107: 3479-92. PMID 22457456 DOI: 10.1152/jn.00789.2011 |
0.595 |
|
| 2009 |
Woolfrey KM, Srivastava DP, Photowala H, Yamashita M, Barbolina MV, Cahill ME, Xie Z, Jones KA, Quilliam LA, Prakriya M, Penzes P. Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nature Neuroscience. 12: 1275-84. PMID 19734897 DOI: 10.1038/Nn.2386 |
0.55 |
|
| 2009 |
Gerachshenko T, Schwartz E, Bleckert A, Photowala H, Seymour A, Alford S. Presynaptic G-protein-coupled receptors dynamically modify vesicle fusion, synaptic cleft glutamate concentrations, and motor behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 10221-33. PMID 19692597 DOI: 10.1523/Jneurosci.1404-09.2009 |
0.337 |
|
| 2009 |
Cahill ME, Xie Z, Day M, Photowala H, Barbolina MV, Miller CA, Weiss C, Radulovic J, Sweatt JD, Disterhoft JF, Surmeier DJ, Penzes P. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proceedings of the National Academy of Sciences of the United States of America. 106: 13058-63. PMID 19625617 DOI: 10.1073/Pnas.0904636106 |
0.331 |
|
| 2008 |
Xie Z, Photowala H, Cahill ME, Srivastava DP, Woolfrey KM, Shum CY, Huganir RL, Penzes P. Coordination of synaptic adhesion with dendritic spine remodeling by AF-6 and kalirin-7. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6079-91. PMID 18550750 DOI: 10.1523/Jneurosci.1170-08.2008 |
0.475 |
|
| 2007 |
Xie Z, Srivastava DP, Photowala H, Kai L, Cahill ME, Woolfrey KM, Shum CY, Surmeier DJ, Penzes P. Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron. 56: 640-56. PMID 18031682 DOI: 10.1016/J.Neuron.2007.10.005 |
0.563 |
|
| 2006 |
Photowala H, Blackmer T, Schwartz E, Hamm HE, Alford S. G protein betagamma-subunits activated by serotonin mediate presynaptic inhibition by regulating vesicle fusion properties. Proceedings of the National Academy of Sciences of the United States of America. 103: 4281-6. PMID 16537522 DOI: 10.1073/Pnas.0600509103 |
0.72 |
|
| 2005 |
Photowala H, Freed R, Alford S. Location and function of vesicle clusters, active zones and Ca2+ channels in the lamprey presynaptic terminal. The Journal of Physiology. 569: 119-35. PMID 16141275 DOI: 10.1113/jphysiol.2005.091314 |
0.606 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Cahill ME, Xie Z, Day M, Photowala H, Barbolina MV, Miller CA, Weiss C, Radulovic J, Sweatt JD, Disterhoft JF, Surmeier DJ, Penzes P. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 31, (13058-13063) DOI:10.1073/pnas. 0904636106)) Proceedings of the National Academy of Sciences of the United States of America. 106: 16890. DOI: 10.1073/Pnas.0909233106 |
0.246 |
|
| 2020 |
Strober B, Menter A, Leonardi C, Gordon K, Lambert J, Puig L, Photowala H, Longcore M, Zhan T, Foley P. Efficacy of Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis by Baseline Demographics, Disease Characteristics and Prior Biologic Therapy: An Integrated Analysis of the Phase III UltIMMa-1 and UltIMMa-2 Studies. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 32320088 DOI: 10.1111/jdv.16521 |
0.036 |
|
| 2023 |
Strober B, Duffin KC, Lebwohl M, Sima A, Janak J, Patel M, Photowala H, Garg V, Bagel J. Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry. The Journal of Dermatological Treatment. 35: 2287401. PMID 38073528 DOI: 10.1080/09546634.2023.2287401 |
0.034 |
|
| 2022 |
Crowley JJ, Langley RG, Gordon KB, Pinter A, Ferris LK, Rubant S, Photowala H, Xue Z, Wu T, Zhan T, Beeck S, Shah M, Warren RB. Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study. Dermatology and Therapy. PMID 35050485 DOI: 10.1007/s13555-021-00679-6 |
0.022 |
|
| 2023 |
Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, et al. Comparison of risankizumab and apremilast for the treatment of adult patients with moderate plaque psoriasis eligible for systemic therapy: results from a randomised, open-label, assessor-blinded phase IV (IMMpulse) study. The British Journal of Dermatology. PMID 37488811 DOI: 10.1093/bjd/ljad252 |
0.019 |
|
| 2022 |
Strober B, Armstrong A, Rubant S, Patel M, Wu T, Photowala H, Crowley J. Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders. The Journal of Dermatological Treatment. 1-9. PMID 35839335 DOI: 10.1080/09546634.2022.2095328 |
0.017 |
|
| 2023 |
Strober B, Ferris L, Callis Duffin K, Janak JC, Sima AP, Eckmann T, Patel M, Photowala H, Garg V, Armstrong A. Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry. Journal of the American Academy of Dermatology. PMID 37739267 DOI: 10.1016/j.jaad.2023.08.097 |
0.012 |
|
| 2024 |
Strober B, Bachelez H, Crowley J, Elewski BE, Gooderham M, Menter A, Strohal R, Chen MM, Wu T, Zhan T, Photowala H, Armstrong A. Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 38179809 DOI: 10.1111/jdv.19748 |
0.01 |
|
| 2023 |
Wu JJ, Patel M, Zeng F, Huang A, Pan X, Cao Y, Chen N, Photowala H, Garg V, Crowley J. Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States. The Journal of Dermatological Treatment. 1-29. PMID 37025014 DOI: 10.1080/09546634.2023.2200869 |
0.01 |
|
| 2007 |
Krugman SD, Suggs A, Photowala HY, Beck A. Redefining the community pediatric hospitalist: the combined pediatric ED/inpatient unit. Pediatric Emergency Care. 23: 33-7. PMID 17228220 DOI: 10.1097/01.pec.0000248685.94647.01 |
0.01 |
|
| 2007 |
Frohna W, King K, Photowala H. Improving Time to Antibiotics in Pneumonia- Does it Save Lives? Academic Emergency Medicine. 14: S161-S161. DOI: 10.1197/J.AEM.2007.03.1161 |
0.01 |
|
| Hide low-probability matches. |